Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04058353
Brief Title: A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

First Submitted : August 14, 2019
First Submitted that Met QC Criteria : August 14, 2019
First Posted : August 15, 2019

Last Update Submitted that Met QC Criteria : July 10, 2020
Last Update Posted : July 13, 2020